Epigallocatechin gallate inhibits hepatitis B virus infection in human liver chimeric mice

Epigallocatechin gallate inhibits hepatitis B virus infection in human liver chimeric mice

Abstract Background Persistent hepatitis B virus (HBV) infection causes liver cirrhosis and hepatocellular carcinoma and constitutes a major worldwide health problem. Currently, anti-HBV drugs are limited to peginterferon and nucleos(t)ide analogs, which are costly and have considerable side effects...

Full description

Bibliographic Details
Main Authors:	Yu-Heng Lai, Cheng-Pu Sun, Hsiu-Chen Huang, Jui-Chieh Chen, Hui-Kang Liu, Cheng Huang
Format:	Article
Language:	English
Published:	BMC 2018-09-01
Series:	BMC Complementary and Alternative Medicine
Subjects:	Hepatitis B virus EGCG HBsAg Human liver chimeric mice
Online Access:	http://link.springer.com/article/10.1186/s12906-018-2316-4

Similar Items

Age-wise and Gender-wise Prevalence of Hepatitis B Virus (HBV) Infection in Lahore, Pakistan
by: Aqib Nazeer, et al.
Published: (2019-12-01)

A comparison on HBsAg and HBsAb prevalence in patients with Down syndrome and other mentally retarded patients living in retarded children institutes in Tehran
by: Sahebjamei M. Associate Professor, et al.
Published: (2003-06-01)

Seroprevalence of Hepatitis B virus Infection by Quantitative Chemiluminescent in Tabriz (North West of Iran), 2010-2011
by: Nader Hajizadeh, et al.
Published: (2014-08-01)

Prediction for HBsAg seroconversion in children with chronic hepatitis B
by: Yan-Wei Zhong, et al.
Published: (2021-12-01)

Seromarkers of Hepatitis B virus in newborns with HBsAg positive mothers
by: Yousef Yahyapour (PhD), et al.
Published: (2009-05-01)

Distinct patterns of serum hepatitis B core-related antigen during the natural history of chronic hepatitis B
by: Zhan-Qing Zhang, et al.
Published: (2017-12-01)

Performance Evaluation of an Improved HBsAg Assay (HBsAg NEXT) for the Detection of HBsAg Levels
by: Ekta Gupta, et al.
Published: (2023-12-01)

Assessing risk of liver enzyme elevation in patients with immune-mediated diseases and different hepatitis B virus serostatus receiving anti-TNF agents: a nested case-control study
by: Ying-Ming Chiu, et al.
Published: (2017-11-01)

Occult hepatitis B virus infection: clearance or disguise?
by: Jin-Wook Kim
Published: (2014-09-01)

Analytical Performance of the Sysmex HISCL HBsAg Assay and Comparison with the Roche Elecsys HBsAg II Quant Assay in the Quantification of Hepatitis B Surface Antigen
by: Joonhong Park, et al.
Published: (2021-11-01)

HBsAg in Cord Blood Qf Newborns of HBsAg-Positive Mothers
by: Adnan S. Wiharta, et al.
Published: (2018-11-01)

Unexpected rise in the circulation of complex HBV variants enriched of HBsAg vaccine-escape mutations in HBV genotype-D: potential impact on HBsAg detection/quantification and vaccination strategies
by: Lorenzo Piermatteo, et al.
Published: (2023-12-01)

Comparative ELISA reagents for detection of hepatitis B surface antigen (HBsAg) Comparação de reativos para o teste de ELISA na evidenciação do antígeno de superfície de hepatite B
by: I. F. Camargo, et al.
Published: (1987-06-01)

Sero-prevalence of Hepatitis B Virus infection in Balochistan province of Pakistan
by: Nadeem S Sheikh, et al.
Published: (2011-01-01)

Epidemiology of Chronic Hepatitis B Infection in the Cohort of College Students with Vaccination in Taiwan
by: Te-Wei Cheng, et al.
Published: (2023-02-01)

Evolution of hepatitis B virus surface gene and protein among Iranian chronic carriers from different provinces
by: Fatemeh Ramezani, et al.
Published: (2015-11-01)

Hepatitis B virus surface antigen seroconversion in HIV-infected individual after pegylated interferon-alpha treatment: a case report
by: Adriane Maira Delicio, et al.
Published: (2013-12-01)

Evaluación serológica de la inmunización pasiva-activa en la profilaxis de la transmisión perinatal de la hepatitis B
by: Marité Bello, et al.
Published: (2012-04-01)

Evaluating the Immunity against Hepatitis B Virus and Frequency of HBsAg Positive Cases among Medical Staff of Shahid Beheshti Hospital in Yasuj, 2016
by: MT Rezanejad, et al.
Published: (2017-12-01)

Lower pretreatment HBV DNA levels are associated with better off-treatment outcomes after nucleo(s)tide analogue withdrawal in patients with HBeAg-neegative chronic hepatitis B: A multicentre cohort study
by: Milan J. Sonneveld, et al.
Published: (2023-08-01)

Functional cure for chronic hepatitis B: accessibility, durability, and prognosis
by: Aixin Song, et al.
Published: (2021-06-01)

Accuracy Validation of the Elecsys HBsAg II Quant Assay and Its Utility in Resolving Equivocal Qualitative HBsAg Results
by: Jaehyeon Lee, et al.
Published: (2023-02-01)

Prevalencia de anticuerpos anti-VHC y del antígeno de superficie de la hepatitis B en pacientes tratados con hemodiálisis Prevalence of anti-HCV antibodies and of the hepatitis B surface antigen in patients treated with hemodialysis
by: Zuzet Martínez Córdova, et al.
Published: (2008-03-01)

Clinical Outcomes and Quantitative HBV Surface Antigen Levels in Diverse Chronic Hepatitis B Patients in Canada: A Retrospective Real-World Study of CHB in Canada (REVEAL-CANADA)
by: Carla S. Coffin, et al.
Published: (2022-11-01)

RNA Interference Therapy for Chronic Hepatitis B Predicts the Importance of Addressing Viral Integration When Developing Novel Cure Strategies
by: Christine I. Wooddell, et al.
Published: (2021-03-01)

Key mutations in the C-terminus of the HBV surface glycoprotein correlate with lower HBsAg levels in vivo, hinder HBsAg secretion in vitro and reduce HBsAg structural stability in the setting of HBeAg-negative chronic HBV genotype-D infection
by: Romina Salpini, et al.
Published: (2020-01-01)

Clinical cure rate of inactive HBsAg carriers with HBsAg <200 IU/ml treated with pegylated interferon
by: Hong Li, et al.
Published: (2022-12-01)

Geographic distribution of HBsAg subtypes in Brazil Distribuição geográfica dos subtipos de antígenos de HBsAg no Brasil
by: Ana Maria Coimbra Gaspar, et al.
Published: (1987-06-01)

Anti-Hepatitis B Antibody Levels In Immunized Medical Students: Are They At Risk?
by: Keila Zaniboni Siqueira Batista, et al.
Published: (2019-05-01)

Clinical implications of HBsAg quantification in patients with chronic hepatitis B
by: Mauro Viganò, et al.
Published: (2012-01-01)

Hepatitis B screening in pregnant women in the autonomous province of Vojvodina, Serbia
by: Rajčević Smiljana, et al.
Published: (2012-01-01)

Functional Cure of Hepatitis B Virus Infection in Individuals With HIV-Coinfection: A Literature Review
by: Anders Boyd, et al.
Published: (2021-07-01)

Status of Hepatitis Be Antigen in Chronic Hepatitis B Patients from Various Regions of Pakistan
by: Agha Babar Hussain
Published: (2017-09-01)

Protection against hepatitis B by the Butang® recombinant vaccine in newborn children in South Brazil
by: Aline Paula Isolani, et al.
Published: (2006-08-01)

Serum hepatitis B virus large and medium surface proteins as novel tools for predicting HBsAg clearance
by: Xiao Lin, et al.
Published: (2022-09-01)

An Increase in the Levels of Middle Surface Antigen Characterizes Patients Developing HBV-Driven Liver Cancer Despite Prolonged Virological Suppression
by: Giuseppina Brancaccio, et al.
Published: (2021-04-01)

Expression and purification of hepatitis B surface antigen S from <it>Escherichia coli</it>; a new simple method
by: Elghanam Mohamed S, et al.
Published: (2012-03-01)

Seroprevalence of hepatitis B surface antigen and its correlation with risk factors among new recruits in Turkey
by: Tulin Altay, et al.

Infección oculta por el virus de la hepatitis B en hijos de madres positivas al HBsAg
by: Marité Bello-Corredor, et al.
Published: (2016-04-01)

Peginterferon alpha-based therapy for chronic hepatitis B focusing on HBsAg clearance or seroconversion: a meta-analysis of controlled clinical trials
by: Zhang Yu-guo, et al.
Published: (2011-06-01)